Another SBM potential 10 bagger springs to life – Phytopharm taking out 52 wk high
We covered Phytopharm extensively in the June edition of our magazine (see here page 13 – http://issuu.com/spreadbetmagazine/docs/spreadbet-magazine-v6_generic) and updated in the latest edition in which we set out the investment case for a potentially very attractive return on the stock should the company’s Phase 2 trials of their primary drug Cogane, which is being used…